BackBellevue Life Sciences Acquisition - Warrants (09/02/2028) Overview

Bellevue Life Sciences Acquisition - Warrants (09/02/2028) Net Tangible Assets

Track Bellevue Life Sciences Acquisition - Warrants (09/02/2028)'s net tangible assets ($150M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$150.92M

Peer average

Loading

Bellevue Life Sciences Acquisition - Warrants (09/02/2028) Net Tangible Assets History

Loading

Bellevue Life Sciences Acquisition - Warrants (09/02/2028) vs. peers: Net Tangible Assets Comparison

Loading

Bellevue Life Sciences Acquisition - Warrants (09/02/2028) Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Bellevue Life Sciences Acquisition - Warrants (09/02/2028) (BLACW) FAQ

As of the most recent data (March 2026), BLACW shows a net tangible assets of $150M. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BLACW's net tangible assets is now $150M (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Bellevue Life Sciences Acquisition - Warrants (09/02/2028) is outperforming or lagging.

Tracking BLACW's net tangible assets over time shows whether Bellevue Life Sciences Acquisition - Warrants (09/02/2028) is scaling, shrinking, or reshaping that part of the business. The current reading is $150M In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Bellevue Life Sciences Acquisition - Warrants (09/02/2028)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $150M) with ownership activity and broader fundamentals.